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Comparison of Mycobacterium tuberculosis genotype distributions in different areas might help to find
determinants of the emergence of certain genotypes, such as the Beijing family. In this study, M. tuberculosis
isolates originating from patients from two Indonesian islands were genotyped, and possible associations with
patients’ characteristics and drug resistance were explored. A high degree of genetic diversity was observed
among the M. tuberculosis strains, and a significant difference was found in the geographical distribution of
genotype families. The predominant Beijing genotype family was isolated from 268 of 813 patients from West
Java (33.0%) versus 12 of 84 patients from Timor (14.3%) (P 0.002). Family F (East African-Indian) (33.3%)
and family D (Latin American and Mediterranean) (20.0%) were more prevalent in Timor. No significant
associations were found between genotype families and age, vaccination with Mycobacterium bovis BCG,
previous treatment, disease localization, or drug resistance. Possible explanations for the differences in the
geographical distribution of the M. tuberculosis genotypes are discussed.
The introduction of DNA fingerprint methods in the early
1990s has greatly improved the possibilities for examining the
transmission of tuberculosis (TB) and the phylogeny of Myco-
bacterium tuberculosis (22). The available genetic fingerprint-
ing methods have different characteristics and applicability. In
particular, analysis of large chromosomal deletions (4) and
single-nucleotide polymorphisms can facilitate meaningful ex-
ploration of the population structure of the M. tuberculosis
complex. However, these methods require sophisticated and
costly techniques. More widespread is the use of spoligotyping
to examine the strain diversity of M. tuberculosis in given areas
(5, 22). By this method, the presence of 43 spacers in the direct
repeat (DR) region of M. tuberculosis complex can be detected.
The loss of spacers in the DR region seems to be in line with
the evolutionary development of the M. tuberculosis complex
lineages, and therefore, this currently appears to be the sim-
plest approach to studying the population structure of M. tu-
berculosis complex strains (18). Because a high number of
spoligotype patterns have been added to a central database,
many M. tuberculosis genotype families could be identified in
the past 15 years, including the Beijing, East African-Indian
(EAI), Haarlem (H), Latin American and Mediterranean
(LAM), and Central Asian (CAS) genotype families (5).
One of the best studied and most widespread evolutionary
lineages of M. tuberculosis is the Beijing genotype family, which
was first found in China and has been reported worldwide (8,
11). The emergence of Beijing genotype strains suggests that
they may have a selective advantage over other M. tuberculosis
strains. Indeed, studies with animal models have shown en-
hanced virulence and distinctive histopathology following in-
fection with M. tuberculosis Beijing genotype strains (6, 16).
Extrapolating from this, the emergence of Beijing and other
genotype families may be the consequence of the application
of two major measures against TB in the last century: Myco-
bacterium bovis BCG vaccination and anti-TB treatment (22).
Possibly, BCG vaccination is less protective against (more-
virulent) Beijing genotype strains than against other strains,
but so far, this has not been proven (2). Similarly, anti-TB
treatment might be less effective in eradicating Beijing strains
than other strains. Indeed, in one study, failure of TB treat-
ment and subsequent relapse were more common among pa-
tients infected with Beijing strains (15). Studies examining a
relationship between the Beijing genotype and drug resistance
have encountered major differences in widespread geographic
areas, according to a systematic review (11).
After India and China, Indonesia has the third highest TB
case load in the world, with an estimated 525,000 new cases
and an estimated 90,000 deaths per year (23). To date, only
one molecular epidemiological study of tuberculosis has been
performed in Indonesia, in 1998 (20). Of 94 TB patients, all
from the capital city, Jakarta, 32.4% were infected with Beijing
genotype strains. The Indonesian archipelago consists of
17,504 islands, inhabited by many different ethnic groups.
Comparison of the distribution of M. tuberculosis genotypes in
different areas or among different human populations and
study of the patients’ characteristics might help to find deter-
minants of the emergence of particular genotype families.
Therefore, we have spoligotyped M. tuberculosis isolates from
a large cohort of patients from two Indonesian islands: West
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Java and Timor. Furthermore, we have explored the distribu-
tion of M. tuberculosis genotype families and analyzed the
possible association of these genotypes with age, sex, BCG
vaccination status, previous TB treatment, disease localization,
and drug resistance.
MATERIALS AND METHODS
Study population. In Indonesia, M. tuberculosis culture is not routinely per-
formed, and there is no national archiving of isolates. Therefore, we prospec-
tively collected isolates from well-characterized patients in two different clinical
studies. In West Java, from January 2001 through December 2006, consecutive
patients over the age of 16 years with microscopically proven pulmonary TB
(PTB) at two outpatient clinics and two hospitals in Jakarta and Bandung (West
Java) were included as part of a large case-control study examining host suscep-
tibility to TB (1). The diagnosis of TB was based on clinical presentation, chest
X-ray examination, microscopic detection of acid-fast bacilli by Ziehl-Neelsen
staining of sputum smears, and culture of M. tuberculosis on 3% Ogawa medium.
As part of the same study, a smaller cohort of microbiologically proven extrapul-
monary TB (EPTB) cases was included. All cultured M. tuberculosis isolates from
patients with PTB (n 740) and EPTB (n 73) were used for the current study.
In addition, in West Timor, as part of a study of micronutrient supplementation
in TB, 84 cultured isolates from PTB patients were included (T. Pakasi et al.,
unpublished data). Of note, these were the first isolates ever cultured in this
less-developed part of Indonesia. For all patients, age, history of previous TB
treatment, the presence or absence of a BCG scar on the left deltoid muscle (as
an approximation of BCG vaccination status), and disease localization were
recorded.
Spoligotyping. DNA was extracted by taking two loopfuls of bacterial mass
from a M. tuberculosis culture in saline and subsequently heating them at 95°C for
5 min. Spoligotyping was performed using a commercial kit (Isogen Bioscience
BV, Maarssen, The Netherlands). The presence or absence of 43 spacers in the
DR region of M. tuberculosis isolates was determined as follows: the DR region
was amplified by primers, one of which was biotinylated; the amplified products
were reverse hybridized to spacer sequence oligonucleotide probes immobilized
on a Biodyne C membrane; and spacer sequences were detected with peroxidase-
labeled streptavidin and enhanced chemiluminescence (9, 13). Spoligotyping was
done at the Hasan Sadikin Hospital, Bandung, Indonesia. For quality control,
spoligotyping of 10% of the isolates, and of all isolates lacking hybridization, was
repeated at Gelre Hospital, Apeldoorn, The Netherlands.
Phylogenetic reconstruction. The spoligotyping results were recorded in octal
and binary formats on an Excel spreadsheet and compared to the international
SpolDB4.0 database (5). Phylogenetic analysis was done using Bionumerics soft-
ware (Applied Maths, Sint-Maartens-Latem, Belgium). Spoligotype patterns
were imported into Bionumerics as a character type; similarities between the
patterns were calculated by using the categorical coefficient; and dendrograms
were prepared by using the unweighted-pair group method using arithmetic
linkages.
DST. Drug susceptibility testing (DST) was performed on cultured isolates
using an absolute concentration method on 7H10 Middlebrook agar in 25-well
plates with supranational control by the National Mycobacteria Reference Lab-
oratory at the RIVM in Bilthoven, The Netherlands. In The Netherlands, this
method has shown 96 to 100% accuracy in 10 rounds of WHO/IUATLD profi-
ciency testing (21). Approximately 10% of the isolates from the current study
were retested at the supranational reference laboratory in The Netherlands.
Data analysis and statistics. Spoligotype patterns were correlated with pa-
tients’ age, sex, and BCG vaccination status (indicated by the presence or ab-
sence of a BCG scar), previous treatment, and resistance to isoniazid (INH),
rifampin, or both drugs (multidrug-resistant [MDR] TB). Differences between
groups were statistically examined using nonparametric tests for continuous
variables and Fisher’s 2 test. To avoid possible confounding by geographical
area, the correlations were examined separately for Java and Timor.
RESULTS
Distribution of M. tuberculosis genotype families. Eighty-
four M. tuberculosis isolates from Timor and 813 isolates from
West Java were collected. Among the isolates from West Java,
740 were isolated from PTB patients and 73 from patients with
EPTB. The latter category consisted of isolates associated with
meningitis (n  42), lymphadenitis (n  9), pleuritis (n  13),
and other diseases (n  9).
A high degree of genetic diversity among the M. tuberculosis
isolates was observed (Table 1). On the basis of the similarities
of their spoligotype patterns, 739 of the 897 isolates were
grouped into nine major spoligotype groups of more than 20
isolates. These nine major spoligotype groups were designated
family A to family I. Spoligotype patterns outside of those nine
major groups were designated “other.” The largest spoligotype
group comprised the Beijing genotype (family I) and contained
280 strains (31.2%). The second largest group was family B
(T1), which consisted of 100 isolates (11.1%). Families E and
A, both representing the Haarlem genotype, contained 82
(9.1%) isolates. In this study, 198 patterns were designated
“orphan” patterns, because they had no shared type pattern in
the international spoligotype database SpolDB4 (Fig. 1). No
unique Indonesian strains were identified.
The distribution of genotypes showed little variation over
time. From 2000 to 2006, 28.9% to 32.7% of the strains be-
longed to the Beijing genotype family, with no obvious trend in
the number of cases over time. Because the distributions of
genotypes in outpatient clinics and hospitals in Jakarta and
Bandung were highly similar, those data were combined
(“West Java”). When the spoligotype patterns originating from
West Java were compared to those from Timor, there ap-
peared to be a significant difference in the distribution of
genotype families. In West Java, M. tuberculosis Beijing geno-
type strains were predominant (33.0%; 95% confidence inter-
val [95% CI], 29.7 to 36.2%), but in Timor, Beijing strains were
much less common (14.3%; 95% CI, 6.8 to 21.8%) (P 0.002).
On the other hand, family F (EAI) and family D (LAM) were
highly prevalent in Timor (33.3% and 20.0%, respectively) but
uncommon in West Java (6.2% and 8.7%, respectively) (Fig.
2). All these differences were statistically significant.
Association of genotype families with patient characteris-
tics. We compared the characteristics of patients infected with
different M. tuberculosis genotype families, including sex, age,
BCG vaccination, previous treatment, and disease localization
(PTB versus EPTB). Because of the strong geographic differ-
ences in the distribution of genotypes, the data from West Java
and Timor were analyzed separately. For the 813 patients
included in West Java, the results are shown in Table 2. The
various genotype families were associated with slight differ-
ences in patient characteristics, none of which were statistically
significant. A BCG scar as an indication of BCG vaccination
was found in only 28.7% of patients. The smallest percentage
of patients with BCG scars was found for those infected with
strains from family C (T in SpolDB4) (16.3%), and the highest
was found for those infected with strains from family A (H in
SpolDB4) (46.3%), but these differences did not reach statis-
tical significance. Similarly, different genotype families showed
slightly different age distributions and percentages of extrapul-
monary localization and previous treatment, but none of these
were statistically significant (Table 2).
To relate the M. tuberculosis genotype to patient character-
istics in Timor (not included in Table 2), we compared the two
largest families in Timor, family F (EAI) (33.3%) and family D
(LAM) (22.0%), with the remaining group including all strains
of other genotypes (46.7%). The median age of patients in-
fected with strains of family D/LAM (23 years) was signifi-
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cantly different from the median age of those infected with
strains of family F/EAI (29 years) or infected with other ge-
notypes (32 years) (P  0.010). No significant differences be-
tween genotype families were found for other patient charac-
teristics. When the 12 (14.3%) patients infected with the
Beijing genotype were analyzed separately, they appeared to
be older than patients infected with other strains (median age,
46 years; interquartile range, 24.3 to 57.5 years), but this dif-
ference was not statistically significant.
Association of genotype families with drug resistance. Drug
resistance patterns were available for 694 isolates: 620 from
West Java, and 74 from Timor. Among the isolates of previ-
ously treated patients (n  77), 25.4% were INH resistant,
31.2% were rifampin resistant, and 17.9% were MDR. Among
newly treated patients (n  617), these rates were 7.5%, 6%,
and 2.6%, respectively. The various genotype families showed
slightly different rates of drug resistance. Resistance to INH
ranged from 2.7% to 10%, and resistance to rifampin ranged
from 2.7% to 11.2%. Because the number of drug-resistant
isolates per genotype family was small, no meaningful statisti-
cal analysis could be done on those differences between the
nine genotype families.
Several previous studies have reported an association be-
tween the Beijing genotype and drug resistance. However, the
drug resistance patterns of 209 Beijing isolates (30.1%) and
485 non-Beijing isolates (69.9%) were not significantly differ-
ent (Table 2). Also, when strains isolated from Java were
analyzed separately, no association was found between the
Beijing genotype and drug resistance.
DISCUSSION
This is the second study of the molecular epidemiology of
TB in Indonesia, involving the two most densely populated
cities in West Java and a more rural area on Timor at the
eastern end of the archipelago. Consecutive patients with mi-
croscopically proven TB from a large cohort study in various
clinics in 2001 to 2006 were included, and patients were care-
fully characterized and followed prospectively. Because the
isolates came from only three areas, the study is not represen-
tative of Indonesia as a whole. However, the four clinics in
West Java showed very similar M. tuberculosis genotype family
distributions, suggesting that these data are indeed represen-
tative for this area.
A high genetic diversity among M. tuberculosis isolates was
found in Indonesia: nine major M. tuberculosis genotypes were
identified. This high genetic M. tuberculosis strain diversity is in
contrast with the findings of studies from other high-preva-
lence areas, including, e.g., Vietnam, where only two major
genotype families were found: Beijing and EAI (15). The M.
TABLE 1. Spoligotype diversity and spoligotype family designation of 897 M. tuberculosis isolates from West Java and Timor
Spoligotype family
designation from SpolDB4
No. of isolates with the following spoligotype family designation from this study: Total
no. of
isolates
No. of
patternsA B C D E F G H I Other
BEIJING 275 275 6
BEIJING-LIKE 5 5 2
CAS 2 2 1
CAS1_DELHI 3 3 1
EAI2_MANILLA 13 13 3
EAI2_NTB 7 7 1
EAI3_IND 3 3 1
EAI5 16 16 8
EAI6_BGD1 1 1 1
EAI1_SOM 16 16 4
H1 20 20 6
H3 40 9 1 50 9
H3-T3 2 2 1
LAM1 8 1 9 2
LAM3 1 1 1
LAM3 and S/convergent 2 2 1
LAM6 3 3 2
LAM8 28 28 1
LAM9 15 1 16 5
MANU2 3 3 1
Orphan 1 17 15 33 8 24 7 108 213 198
S 7 1 8 3
T1 55 4 2 3 10 74 20
T1(T4-CE1?) 1 1 1
T2 9 1 10 4
T2-T3 4 4 1
T3 3 24 27 2
T5_RUS1 1 1 1
U 1 1 7 3 15 27 14
U (LIKELYH3) 27 27 2
U (likelyS) 26 26 1
X1 1 3 4 3
Total 41 100 43 90 41 74 41 29 280 158 897 307
VOL. 46, 2008 M. TUBERCULOSIS POPULATION STRUCTURES IN INDONESIA 3641
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FIG. 1. Diagram of the 198 orphan spoligotype patterns found in this study, with a dendrogram on the left showing the similarities among the
patterns. The number of isolates of each spoligotype is given on the right.
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tuberculosis Beijing genotype family was the most prevalent
genotype family in Indonesia (31.2%), and the proportion of
Beijing strains was stable during the study period and similar to
the prevalence recorded in a previous, smaller study (32.4%)
(20). In contrast to what has been reported in other studies (2,
7, 15), no association was found between the Beijing genotype
and age, previous treatment, or BCG vaccination. As demon-
strated previously in other studies from Asia, no clear associ-
ation was found between drug resistance and Beijing strains, in
contrast to reports from, e.g., the republics of the former So-
viet Union, Cuba, South Africa, and Vietnam (8).
Interestingly, a strong difference was found between the M.
tuberculosis population structures in West Java and Timor. The
Beijing genotype family was found in 33.0% of patients in Java
versus 14.3% of patients in Timor. This is in line with a recent
observation in Vietnam, where a frequency of 50% in Ho Chi
Minh City, but only 30% in the Mekong Delta, was found for
Beijing genotype strains (unpublished data). These differences
suggest that transmission of Beijing genotype strains may ben-
efit from highly dense populations. Inversely, in Timor, the
EAI and LAM genotype families were predominant, while
these genotypes were uncommon in Java. One can only hy-
pothesize about the explanation for this difference. First, this
difference may be due to a “founder effect,” with a higher
chance of finding a particular genotype family closer to where
it originated. Second, it may also indicate that particular my-
cobacterial lineages have adapted to particular human popu-
lations. This concept of genetic host-pathogen compatibility is
supported by data showing a preferential spread of particular
lineages among patient populations from the same area rather
than from other areas (10, 12). So far, no studies showing
direct associations between the genetic characteristics of TB
patients and their (own) mycobacterial isolates have been re-
ported.
Finally, the predominance of certain genotype families, par-
ticularly the Beijing genotype family, might also be explained
by other mechanisms, such as higher transmission rates or
“escape” from BCG vaccination. Our results do not support
these hypotheses, since no significant associations were found
between particular genotype families and patient characteris-
tics, especially age and BCG vaccination status. However, the
coverage of BCG vaccination is very high in Indonesia. Hence,
transmission from vaccinated to nonvaccinated individuals is
so frequent that differences between the populations of strains
in the two groups will be diluted easily.
Several studies, such as one in Vietnam, have reported a
lower age of patients infected with Beijing strains (2), suggest-
ing more-recent transmission of Beijing strains. A second study
from a different area in Vietnam has found a similar relation-
ship between age and genotype (T. N. Buu, submitted for
publication), but we, like others (7, 19), did not find this asso-
ciation. In fact, among patients from Timor, those infected
FIG. 2. Distribution of M. tuberculosis genotype families in West
Java and Timor. *, P  0.05.
TABLE 2. M. tuberculosis genotype families and associated patient characteristics in West Java
Patient characteristica
Result for the following spoligotype familyb:
A (H) B (T) C (T) D (LAM) E (H) F (EAI) G (Ulikely H3)
H (U
likely S) I (Beijing) Other Total
No. (%) 41 (5) 98 (12.1) 43 (5.3) 71 (8.7) 40 (4.9) 50 (6.2) 37 (4.6) 27 (3.3) 268 (33.0) 138 (17.0) 813 (100)
Age (yr)
Median 26.0 28.5 30.0 28.0 27.0 34.5 27.0 27.0 30.0 35.0 30
IQR 20.5–36.0 23.0–42.0 24.0–46.0 23.0–39.0 21.3–41.8 24.0–46.3 22.5–40.0 20.0–41.0 23.0–41.0 25.0–47.0 23.0–43.0
Male 43.9 58.2 48.8 56.3 52.5 52.0 54.1 48.1 49.3 50.7 51.4
BCG scarc 46.3 24.5 16.3 29.6 30.0 22.0 24.3 22.2 28.0 35.5 28.7
Previous TB
treatment
12.2 16.3 4.7 8.5 10.0 20.0 10.8 18.5 9.7 12.3 11.7
Disease localization
Extrapulmonary 2.4 9.2 7.0 7.0 0.0 4.0 2.7 25.9 11.2 10.9 9.0
Pulmonary 97.6 90.8 93.0 93.0 100.0 96.0 97.3 74.1 88.8 89.1 91.0
Drug resistanced
Isoniazid (R  I) 17.1 14.3 11.6 7.0 17.5 14.0 10.8 11.1 13.1 9.4 12.3
Isoniazid (R only) 9.8 7.1 7.0 4.2 7.5 10.0 2.7 3.7 8.2 5.1 6.9
Rifampin 7.3 11.2 4.7 5.6 10.0 8.0 2.7 7.4 5.6 7.2 6.9
MDR 7.3 4.1 2.3 2.8 5.0 6.0 0.0 3.7 3.7 4.3 3.9
a Except where otherwise indicated, each data point is the percentage of patients with the indicated characteristic. IQR, interquartile range; R, resistant; I,
intermediate.
b Given as the spoligotype family designation from this study (spoligotype family designation from SpolDB4).
c Evaluated for 565 patients.
d DST was successful for 694 isolates.
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with a Beijing strain were older, although the number was
small. The difference between Indonesia and Vietnam may be
explained by the existence of different evolutionary lineages of
the Beijing genotype family circulating in different geographic
areas, as has been demonstrated previously (17).
In Indonesia, DST of M. tuberculosis is a matter of concern.
Indonesia is not included in international surveillance of drug
resistance (3), and there is no national surveillance or quality
control system. We have previously compared the quality of
conventional (proportional) DST with that of the 25-well DST
method (21) in Indonesia, and the 25-well DST method used in
this study showed better performance on WHO reference
strains (B. Alisjahbana et al., submitted for publication). How-
ever, the high rates of drug resistance found in this study are in
contrast with the only recent peer-reviewed data on drug re-
sistance in Indonesia and with rates in neighboring countries
(14). Because most of the isolates in this study came from
clinics, care should be taken in the interpretation of the high
drug resistance rate observed. Drug resistance rates in a more
nationally representative DST survey may not be as high. It is
clear that there is an urgent need for widespread implemen-
tation of quality-assured DST in Indonesia. Because of the
limited number of strains belonging to certain genotype fam-
ilies, a possible relationship between particular genotypes and
drug resistance cannot be excluded.
In conclusion, this molecular epidemiological study in Indo-
nesia shows a considerable degree of heterogeneity among M.
tuberculosis isolates and a significant difference in M. tubercu-
losis population structures at the different geographical study
sites. A nationwide survey can provide more detail on the
distribution of different genotype families in Indonesia, and a
study of possible associations between host and mycobacterial
genetics may help to establish if differences in M. tuberculosis
population structures are caused by evolutionary adaptation of
particular mycobacterial lineages to certain human popula-
tions.
ACKNOWLEDGMENTS
We thank Halim Danusantoso and A. Marion, principals of the
Central Jakarta Tuberculosis Association Clinic, Cissy B. Sudjana
Prawira, director of Hasan Sadikin General Hospital, and Hedi B.
Sampoerno, director of the Bandung Tuberculosis and Lung Clinic, for
encouraging and accommodating research in their institutions.
This study was financially supported by the Scientific Programme
Indonesia Netherlands (SPIN), funded by the Royal Academy of Arts
and Sciences (KNAW), The Netherlands; the Poverty Related Infec-
tion Oriented Research (PRIOR) network, funded by the Netherlands
Foundation for Advancement of Tropical Research (NWO-WOTRO);
and the Riset Unggulan Terpadu Internasional (149B-3/SK/RUTI/
2002), organized by the Indonesian Ministry of Research and Tech-
nology. I. Parwati has a fellowship from NWO-WOTRO (WB 93-419),
and R. van Crevel has a fellowship from the Netherlands Organization
for Health Research and Development (ZonMw). The RIVM received
support from the European Union, project TBadapt (037919).
REFERENCES
1. Alisjahbana, B., E. Sahiratmadja, E. J. Nelwan, A. M. Purwa, Y. Ahmad,
T. H. Ottenhoff, R. H. Nelwan, I. Parwati, J. W. van der Meer, and R. van
Crevel. 2007. The effect of type 2 diabetes mellitus on the presentation and
treatment response of pulmonary tuberculosis. Clin. Infect. Dis. 45:428–435.
2. Anh, D. D., M. W. Borgdorff, L. N. Van, N. T. Lan, T. van Gorkom, K.
Kremer, and D. van Soolingen. 2000. Mycobacterium tuberculosis Beijing
genotype emerging in Vietnam. Emerg. Infect. Dis. 6:302–305.
3. Aziz, M. A., A. Wright, A. Laszlo, A. De Muynck, F. Portaels, A. Van Deun,
C. Wells, P. Nunn, L. Blanc, and M. Raviglione. 2006. Epidemiology of
antituberculosis drug resistance (the Global Project on Anti-tuberculosis
Drug Resistance Surveillance): an updated analysis. Lancet 368:2142–2154.
4. Brosch, R., S. V. Gordon, M. Marmiesse, P. Brodin, C. Buchrieser, K.
Eiglmeier, T. Garnier, C. Gutierrez, G. Hewinson, K. Kremer, L. M. Par-
sons, A. S. Pym, S. Samper, D. van Soolingen, and S. T. Cole. 2002. A new
evolutionary scenario for the Mycobacterium tuberculosis complex. Proc.
Natl. Acad. Sci. USA 99:3684–3689.
5. Brudey, K., J. R. Driscoll, L. Rigouts, W. M. Prodinger, A. Gori, S. A.
Al-Hajoj, C. Allix, L. Aristimuno, J. Arora, V. Baumanis, L. Binder, P.
Cafrune, A. Cataldi, S. Cheong, R. Diel, C. Ellermeier, J. T. Evans, M.
Fauville-Dufaux, S. Ferdinand, D. Garcia de Viedma, C. Garzelli, L. Gaz-
zola, H. M. Gomes, M. C. Guttierez, P. M. Hawkey, P. D. van Helden, G. V.
Kadival, B. N. Kreiswirth, K. Kremer, M. Kubin, S. P. Kulkarni, B. Liens,
T. Lillebaek, M. L. Ho, C. Martin, C. Martin, I. Mokrousov, O. Narvskaia,
Y. F. Ngeow, L. Naumann, S. Niemann, I. Parwati, Z. Rahim, V. Rasolofo-
Razanamparany, T. Rasolonavalona, M. L. Rossetti, S. Rusch-Gerdes, A.
Sajduda, S. Samper, I. G. Shemyakin, U. B. Singh, A. Somoskovi, R. A.
Skuce, D. van Soolingen, E. M. Streicher, P. N. Suffys, E. Tortoli, T.
Tracevska, V. Vincent, T. C. Victor, R. M. Warren, S. F. Yap, K. Zaman, F.
Portaels, N. Rastogi, and C. Sola. 2006. Mycobacterium tuberculosis complex
genetic diversity: mining the fourth international spoligotyping database
(SpolDB4) for classification, population genetics and epidemiology. BMC
Microbiol. 6:23.
6. Dormans, J., M. Burger, D. Aguilar, R. Hernandez-Pando, K. Kremer, P.
Roholl, S. M. Arend, and D. van Soolingen. 2004. Correlation of virulence,
lung pathology, bacterial load and delayed type hypersensitivity responses
after infection with different Mycobacterium tuberculosis genotypes in a
BALB/c mouse model. Clin. Exp. Immunol. 137:460–468.
7. Drobniewski, F., Y. Balabanova, V. Nikolayevsky, M. Ruddy, S. Kuznetzov,
S. Zakharova, A. Melentyev, and I. Fedorin. 2005. Drug-resistant tubercu-
losis, clinical virulence, and the dominance of the Beijing strain family in
Russia. JAMA 293:2726–2731.
8. European Concerted Action on New Generation Genetic Markers and Tech-
niques for the Epidemiology and Control of Tuberculosis. 2006. Beijing/W
genotype Mycobacterium tuberculosis and drug resistance. Emerg. Infect. Dis.
12:736–743.
9. Filliol, I., J. R. Driscoll, D. Van Soolingen, B. N. Kreiswirth, K. Kremer, G.
Valetudie, D. D. Anh, R. Barlow, D. Banerjee, P. J. Bifani, K. Brudey, A.
Cataldi, R. C. Cooksey, D. V. Cousins, J. W. Dale, O. A. Dellagostin, F.
Drobniewski, G. Engelmann, S. Ferdinand, D. Gascoyne-Binzi, M. Gordon,
M. C. Gutierrez, W. H. Haas, H. Heersma, G. Kallenius, E. Kassa-Kelem-
bho, T. Koivula, H. M. Ly, A. Makristathis, C. Mammina, G. Martin, P.
Mostrom, I. Mokrousov, V. Narbonne, O. Narvskaya, A. Nastasi, S. N.
Niobe-Eyangoh, J. W. Pape, V. Rasolofo-Razanamparany, M. Ridell, M. L.
Rossetti, F. Stauffer, P. N. Suffys, H. Takiff, J. Texier-Maugein, V. Vincent,
J. H. De Waard, C. Sola, and N. Rastogi. 2002. Global distribution of
Mycobacterium tuberculosis spoligotypes. Emerg. Infect. Dis. 8:1347–1349.
10. Gagneux, S., and P. M. Small. 2007. Global phylogeography of Mycobacte-
rium tuberculosis and implications for tuberculosis product development.
Lancet Infect. Dis. 7:328–337.
11. Glynn, J. R., J. Whiteley, P. J. Bifani, K. Kremer, and D. van Soolingen.
2002. Worldwide occurrence of Beijing/W strains of Mycobacterium tubercu-
losis: a systematic review. Emerg. Infect. Dis. 8:843–849.
12. Hanekom, M., G. D. van der Spuy, N. C. Gey van Pittius, C. R. McEvoy, S. L.
Ndabambi, T. C. Victor, E. G. Hoal, P. D. van Helden, and R. M. Warren.
2007. Evidence that the spread of Mycobacterium tuberculosis strains with the
Beijing genotype is human population dependent. J. Clin. Microbiol. 45:
2263–2266.
13. Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S.
Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. D. van
Embden. 1997. Simultaneous detection and strain differentiation of Myco-
bacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol.
35:907–914.
14. Kelly, P. M., L. Scott, and V. L. Krause. 2002. Tuberculosis in East Timorese
refugees: implications for health care needs in East Timor. Int. J. Tuberc.
Lung Dis. 6:980–987.
15. Lan, N. T., H. T. Lien, B. Tung Le, M. W. Borgdorff, K. Kremer, and D. van
Soolingen. 2003. Mycobacterium tuberculosis Beijing genotype and risk for
treatment failure and relapse, Vietnam. Emerg. Infect. Dis. 9:1633–1635.
16. Lo´pez, B., D. Aguilar, H. Orozco, M. Burger, C. Espitia, V. Ritacco, L.
Barrera, K. Kremer, R. Hernandez-Pando, K. Huygen, and D. van Soolin-
gen. 2003. A marked difference in pathogenesis and immune response in-
duced by different Mycobacterium tuberculosis genotypes. Clin. Exp. Immu-
nol. 133:30–37.
17. Mokrousov, I., H. M. Ly, T. Otten, N. N. Lan, B. Vyshnevskyi, S. Hoffner,
and O. Narvskaya. 2005. Origin and primary dispersal of the Mycobacterium
tuberculosis Beijing genotype: clues from human phylogeography. Genome
Res. 15:1357–1364.
18. Smith, N. H., K. Kremer, J. Inwald, J. Dale, J. R. Driscoll, S. V. Gordon, D.
van Soolingen, R. G. Hewinson, and J. M. Smith. 2006. Ecotypes of the
Mycobacterium tuberculosis complex. J. Theor. Biol. 239:220–225.
3644 PARWATI ET AL. J. CLIN. MICROBIOL.
 o
n
 July 12, 2012 by Universiteitsbibliotheek
http://jcm.asm.org/
D
ow
nloaded from
 
19. Sun, Y. J., A. S. Lee, S. Y. Wong, H. Heersma, K. Kremer, D. van Soolingen,
and N. I. Paton. 2007. Genotype and phenotype relationships and transmis-
sion analysis of drug-resistant tuberculosis in Singapore. Int. J. Tuberc. Lung
Dis. 11:436–442.
20. van Crevel, R., R. H. Nelwan, W. de Lenne, Y. Veeraragu, A. G. van der
Zanden, Z. Amin, J. W. van der Meer, and D. van Soolingen. 2001. Myco-
bacterium tuberculosis Beijing genotype strains associated with febrile re-
sponse to treatment. Emerg. Infect. Dis. 7:880–883.
21. van Klingeren, B., M. Dessens-Kroon, T. van der Laan, K. Kremer, and D.
van Soolingen. 2007. Drug susceptibility testing of Mycobacterium tubercu-
losis complex by use of a high-throughput, reproducible, absolute concen-
tration method. J. Clin. Microbiol. 45:2662–2668.
22. Van Soolingen, D. 2001. Molecular epidemiology of tuberculosis and other
mycobacterial infections: main methodologies and achievements. J. Intern.
Med. 249:1–26.
23. World Health Organization. 2007. WHO Report 2007. Global tuberculosis
control, surveillance, planning, financing. WHO/HTM/TB/2007.376. http:
//www.who.int/tb/publications/global_report/2007/en/.
VOL. 46, 2008 M. TUBERCULOSIS POPULATION STRUCTURES IN INDONESIA 3645
 o
n
 July 12, 2012 by Universiteitsbibliotheek
http://jcm.asm.org/
D
ow
nloaded from
 
